Bard Eclipse IVC Filter

bard eclipse ivc filterDid you or a loved one experience complications related to the fracture, migration or embolization of C.R. Bard, Inc.’s Eclipse IVC filter? Plaintiffs around the U.S. are currently pursuing product liability claims for serious and life-threatening injuries that were allegedly caused by Bard’s retrievable IVC filter devices.

Contact a Bard IVC Filter Lawsuit Attorney

The medical device practice group at Bernstein Liebhard LLP is now evaluating potential IVC filter lawsuits involving products manufactured by C.R. Bard, including the Eclipse Retrievable IVC Filter. If you would like to discuss such a case with one of our attorneys, please call (888) 994-5118.

Retrievable IVC Filter Complications

Retrievable IVC filters such as Bard’s Eclipse device are implanted into the inferior vena cava, where their wire, spider-like struts catch blood clots before they can travel to the lungs and become a pulmonary embolism. The filters are indicated for use in patients for whom anticoagulant therapy is not appropriate, and they are intended to be removed from the body once the threat of pulmonary embolism has passed.

A growing number of IVC filter lawsuits have been filed against C.R. Bard on behalf of patients who allegedly experience severe and life-threatening complications due to the company’s retrievable IVC filters. Complications noted in these lawsuits include:

  • Internal bleeding
  • Cardiac tamponade
  • Severe pain
  • Puncture of the Inferior vena cava
  • Pulmonary embolism
  • Respiratory distress
  • Deep vein thrombosis in lower limbs
  • Death

FDA IVC Filter Warnings

Since 2010, the U.S. Food & Drug Administration (FDA) has issued two safety communications regarding possible safety issues associated with retrievable IVC filters.

  • In a 2010, the FDA disclosed that it had received more than 900 reports involving problems with retrievable filters, some of which resulted in adverse clinical outcomes. The reports included instance of filter migration (328 cases); embolization (146 reports); filter perforation (70 instances); and filter fracture (56 reports). The agency also advised that many of the incidents may have been related to a retrievable filter remaining in the body long after the risk of pulmonary embolism had subsided.
  • In 2014, the FDA issued a second alert to again remind doctors about the importance of retrieving IVC filters, recommending that the devices be removed between29 and 54 days after implantation.

Potential Problems with the Bard Eclipse IVC Filter

The Eclipse retrievable filter is just one of a number of IVC filters manufactured by C.R. Bard. It is very similar in design to another Bard product called the G2 Retrievable IVC filter, except that it has an electropolished finish that is much smoother than the G2’s.

One recent study involving 548 people implanted with a Bard Recovery, G2, or G2 Express IVC filter indicated that the device was associated with a 12% fracture rate. In 13% of the filter fracture cases, the broken components embolized to other areas of the body. While the study does not prove that the Eclipse IVC filter poses the same risk of fracture, the similarities in design between it and G2 could be cause for concern.

Bard IVC Filter Litigation News

  • December 2015: A Mississippi man has filed a Bard Eclipse IVC filter lawsuit alleging the device was defectively designed and manufactured. The plaintiff suffered the  perforation of his inferior vena cava, which allegedly occurred after the filter “grossly tilted” out of position. Read More
  • August 2015: Federally-filed Bard IVC filter lawsuits have been consolidated in the U.S. District Court, District of Arizona, for the purpose of coordinated pretrial proceedings. By December 2015, the litigation had grown to include more than 60 cases, with new filings being reported in courts around the U.S. Read More

Information on Filing a Eclipse IVC Filter Lawsuit

Bernstein Liebhard LLP is now offering free, no-obligation legal reviews to anyone who suffered serious complications that may related to the Eclipse Retrievable IVC Filter. To learn whether or not your injuries might qualify for compensation, please call (888) 994-5118.

  1. FDA (2010) “Removing retrievable Interior Vena Cava Filters: Initial Communication”
  2. FDA (2014) “Removing retrievable Interior Vena Cava Filters: FDA Communication”
  3. Journal of Vascular and Interventional Radiology (2012) “Fractured Bard Recovery, G2, and G2 express inferior vena cava filters: incidence, clinical consequences, and outcomes of removal attempts.”
Last Modified: January 6, 2016

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.


Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest

Skip to content